Raptiva Lawsuit News and Information
Raptiva Lawsuits
The psoriasis drug Raptiva’s side effects could lead to serious and potentially life-threatening infections, including the rare brain disease progressive multifocal leukoencephalopathy (PML). A Raptiva recall was issued because the risk of developing this deadly infection outweighs the benefits provided by the drug.
All Articles Tagged With: "Raptiva"
Additional PML Brain Infection Cases Linked to Tysabri and Rituxan
New cases of a rare brain infection, progressive multifocal leukoencephalopathy (PML), have been liked to the lymphoma and arthritis drug Rituxan and the multiple sclerosis (MS) drug Tysabri. The cases have regulators in the U.S. and Europe searching for ways to reduce the risks of patients developing the often fatal brain infection.
Tysabri Reactivates JC Virus Linked to Rare Brain Disease: Study
A new study indicates that side effects of Tysabri, a multiple sclerosis drug, reactivates and strengthens a virus that can cause a deadly brain infection, known as progressive multifocal leukoencephalopathy (PML). Tysabri was briefly removed from the market in 2005 after several patients died from the brain infection, and at least 13 Tysabri PML [...]
PML Brain Infection from Tysabri Reported in 10th Patient
Biogen Idec Inc. is reporting that another brain infection from Tysabri has been discovered among users of their multiple sclerosis drug, which is at least the 10th case reported in the last three years.
Tysabri Side Effects Linked to 9th PML Infection Case
A new case of a rare, often lethal, brain infection has been linked to the multiple sclerosis drug Tysabri, making it the ninth case of progressive multifocal leukoencephalopathy (PML) infection potentially caused by side effects of Tysabri since the drug was put back on the market in July 2006.
Another Tysabri Brain Infection Reported: 8th PML Infection Since Re-Launch
Biogen Idec Inc. indicates that another multiple sclerosis patient may have developed a rare and potentially life-threatening brain infection known as progresive multifocal leukoencephalopathy from side effects of Tysabri.
Recall for Raptiva Finalized Due to Brain Infection Risk
The complete recall of the psoriasis drug Raptiva throughout the United States and participating countries of the European Union will be finalized this week, after sales were suspended earlier this year due to the risk of serious Raptiva side effects, including a fatal brain infection known as progressive multifocal leukoencephalopathy (PML).
Rituxan Fatal Infections Lead FDA to Review Risk of Side Effects
Following reports that link side effects of Rituxan to fatal brain infections, the FDA is reviewing whether users of the cancer-fighting drug should use the medication for shorter periods of time or take “drug holidays” to reduce the risk.
Rituxan PML Brain Infections Reported in 57 People
A new study indicates that at least 57 patients being treated with the lymphoma-fighting drug Rituxan have developed a rare brain infection, known as progressive multifocal leukoencephalitis (PML), and the cases have involved a 90% fatality rate.
Tysabri Brain Infection Reported in another Multiple-Sclerosis Patient
According to a report in the Wall Street Journal, another multiple sclerosis patient has developed a rare and often fatal brain infection, known as progressive multifocal leukoencephalopathy, or PML, as a possible side effect of Tysabri.
Raptiva Infection Lawsuit Filed in California After Recall
A complaint was filed last week in California on behalf of a three psoriasis patients who allegedly suffered serious side effects of Raptiva. The lawsuit was filed on April 9, 2009, the day after Genentech announced that they were issuing a Raptiva recall in the United States due to an increased risk of infections [...]
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
